Systematic multi-trait AAV capsid engineering for efficient gene delivery
Eid, F.-E.; Chen, A. T.; Chan, K. Y.; Huang, Q.; Zheng, Q.; Tobey, I. G.; Pacouret, S.; Brauer, P. P.; Keyes, C.; Powell, M.; Johnston, J.; Zhao, B.; Lage, K.; Tarantal, A. F.; Chan, Y. A.; Deverman, B. E.
Show abstract
Broadening gene therapy applications requires manufacturable vectors that efficiently transduce target cells in humans and preclinical models. Conventional selections of adeno-associated virus (AAV) capsid libraries are inefficient at searching the vast sequence space for the small fraction of vectors possessing multiple traits essential for clinical translation. Here, we present Fit4Function, a generalizable machine learning (ML) approach for systematically engineering multi-trait AAV capsids. By leveraging a capsid library that evenly samples the manufacturable sequence space, reproducible screening data are generated to train accurate sequence-to-function models. Combining six models, we designed a multi-trait (liver-targeted, manufacturable) capsid library and validated 89% of library variants on all six predetermined criteria. Furthermore, the models, trained only on mouse in vivo and human in vitro Fit4Function data, accurately predicted AAV capsid variant biodistribution in macaque. Top candidates exhibited high production yields, efficient murine liver transduction, up to 1000-fold greater human hepatocyte transduction, and increased enrichment, relative to AAV9, in a screen for liver transduction in macaques. The Fit4Function strategy ultimately makes it possible to predict cross-species traits of peptide-modified AAV capsids and is a critical step toward assembling an ML atlas that predicts AAV capsid performance across dozens of traits.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice 95%
- Human cell surface-AAV interactomes identify LRP6 as blood-brain-barrier transcytosis receptor and immune cytokine IL3 as AAV9 binder 94%
- Precision Cas9 Genome Editing in vivo with All-in-one, Self-targeting AAV Vectors 94%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralising SARS-CoV-2 nanobodies 94%
- Optimal trade-off control in machine learning-based library design, with application to adeno-associated virus (AAV) for gene therapy 93%
- Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.